ITOS
Iteos Therapeutics, Inc.
10% owner Ansbert Gadicke sold $4.8M of Iteos Therapeutics, Inc.
Sold$4,817,417
$34.47Price
139,773Shares
−3%Stake
What ITOS did after the filing
- The stock from Thu, Dec 2 close, $35.07
- +13.1%
- S&P 500, same days
- +2.0%
Measured over 30 trading days, to the Jan 14 close.
Traded Tue, Nov 30. Filed Thu, Dec 2, 1:53 PM ET, during the session. Returns use the Dec 2 close and the Jan 14 close. Not investment advice.